<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Mymetics Corp — News on 6ix</title>
    <link>https://6ix.com/company/mymetics-corp</link>
    <description>Latest news and press releases for Mymetics Corp on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 31 Aug 2022 06:00:27 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/mymetics-corp" rel="self" type="application/rss+xml" />
    <item>
      <title>Mymetics and PCI Biotech Sign a Preclinical Research Collaboration</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-and-pci-biotech-sign-a-preclinical-research-collaboration</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-and-pci-biotech-sign-a-preclinical-research-collaboration</guid>
      <pubDate>Wed, 31 Aug 2022 06:00:27 GMT</pubDate>
      <description>Mymetics and PCI Biotech Sign a Preclinical Research Collaboration.</description>
    </item>
    <item>
      <title>Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-to-advance-preclinical-studies-for-virosome-based-covid-19-vaccine-through-innosuisse-grant</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-to-advance-preclinical-studies-for-virosome-based-covid-19-vaccine-through-innosuisse-grant</guid>
      <pubDate>Wed, 18 Nov 2020 08:00:55 GMT</pubDate>
      <description>Mymetics to Advance Preclinical Studies for Virosome-based COVID-19 Vaccine through Innosuisse Grant.</description>
    </item>
    <item>
      <title>Mymetics Starts Second Preclinical Study for Virosome-based Covid-19 Vaccine</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-starts-second-preclinical-study-for-virosome-based-covid-19-vaccine</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-starts-second-preclinical-study-for-virosome-based-covid-19-vaccine</guid>
      <pubDate>Mon, 02 Nov 2020 13:02:37 GMT</pubDate>
      <description>Mymetics Starts Second Preclinical Study for Virosome-based Covid-19 Vaccine.</description>
    </item>
    <item>
      <title>Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-starts-preclinical-studies-with-baylor-college-of-medicine-for-virosome-based-covid-19-vaccine</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-starts-preclinical-studies-with-baylor-college-of-medicine-for-virosome-based-covid-19-vaccine</guid>
      <pubDate>Wed, 23 Sep 2020 10:01:21 GMT</pubDate>
      <description>Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine.</description>
    </item>
    <item>
      <title>Mymetics Receives Support for Virosome-based Covid-19 Vaccine Development from European Vaccine Infrastructure Project (Transvac2)</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-receives-support-for-virosome-based-covid-19-vaccine-development-from-european-vaccine-infrastructure-project-transvac2</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-receives-support-for-virosome-based-covid-19-vaccine-development-from-european-vaccine-infrastructure-project-transvac2</guid>
      <pubDate>Thu, 11 Jun 2020 06:02:06 GMT</pubDate>
      <description>Mymetics Receives Support for Virosome-based Covid-19 Vaccine Development from European Vaccine Infrastructure Project (Transvac2).</description>
    </item>
    <item>
      <title>Mymetics Reports Successful Preclinical Study Results with COP-Virosomes as Second-Generation Allergy Immunotherapy</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-reports-successful-preclinical-study-results-with-cop-virosomes-as-second-generation-allergy-immunotherapy</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-reports-successful-preclinical-study-results-with-cop-virosomes-as-second-generation-allergy-immunotherapy</guid>
      <pubDate>Thu, 28 May 2020 07:00:19 GMT</pubDate>
      <description>Mymetics Reports Successful Preclinical Study Results with COP-Virosomes as Second-Generation Allergy Immunotherapy.</description>
    </item>
    <item>
      <title>Mymetics starts Research Project in Cancer Immunotherapy with IO Biotech</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-starts-research-project-in-cancer-immunotherapy-with-io-biotech</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-starts-research-project-in-cancer-immunotherapy-with-io-biotech</guid>
      <pubDate>Mon, 25 May 2020 09:17:53 GMT</pubDate>
      <description>Mymetics starts Research Project in Cancer Immunotherapy with IO Biotech.</description>
    </item>
    <item>
      <title>Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-and-baylor-college-of-medicine-start-research-collaboration-for-virosome-based-covid-19-vaccines</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-and-baylor-college-of-medicine-start-research-collaboration-for-virosome-based-covid-19-vaccines</guid>
      <pubDate>Mon, 18 May 2020 10:00:27 GMT</pubDate>
      <description>Mymetics and Baylor College of Medicine start Research Collaboration for Virosome-based Covid-19 Vaccines.</description>
    </item>
    <item>
      <title>Mymetics Annouces Publication in Npj Vaccines of preclinical study of malaria vaccine</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-annouces-publication-in-npj-vaccines-of-preclinical-study-of-malaria-vaccine</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-annouces-publication-in-npj-vaccines-of-preclinical-study-of-malaria-vaccine</guid>
      <pubDate>Tue, 04 Feb 2020 09:19:35 GMT</pubDate>
      <description>Mymetics Annouces Publication in Npj Vaccines of preclinical study of malaria vaccine.</description>
    </item>
    <item>
      <title>Mymetics Announces New Study to Predict Efficacy of Second- Generation COP Allergy Immunotherpy with Virosomes</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-announces-new-study-to-predict-efficacy-of-second-generation-cop-allergy-immunotherpy-with-virosomes</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-announces-new-study-to-predict-efficacy-of-second-generation-cop-allergy-immunotherpy-with-virosomes</guid>
      <pubDate>Thu, 17 Oct 2019 10:00:31 GMT</pubDate>
      <description>Mymetics Announces New Study to Predict Efficacy of Second- Generation COP Allergy Immunotherpy with Virosomes.</description>
    </item>
    <item>
      <title>Mymetics receives HIV Vaccine Funding from the NIH</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-receives-hiv-vaccine-funding-from-the-nih</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-receives-hiv-vaccine-funding-from-the-nih</guid>
      <pubDate>Mon, 29 Apr 2019 14:38:39 GMT</pubDate>
      <description>Mymetics receives HIV Vaccine Funding from the NIH.</description>
    </item>
    <item>
      <title>Mymetics Receives Funding from NIH for Novel HIV Vaccine Study</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-receives-funding-from-nih-for-novel-hiv-vaccine-study</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-receives-funding-from-nih-for-novel-hiv-vaccine-study</guid>
      <pubDate>Mon, 29 Apr 2019 12:01:42 GMT</pubDate>
      <description>Mymetics Receives Funding from NIH for Novel HIV Vaccine Study.</description>
    </item>
    <item>
      <title>Mymetics Virosomes Successful in Allergy Proof-of-Concept Study</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-virosomes-successful-in-allergy-proof-of-concept-study</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-virosomes-successful-in-allergy-proof-of-concept-study</guid>
      <pubDate>Thu, 13 Dec 2018 07:00:31 GMT</pubDate>
      <description>Mymetics Virosomes Successful in Allergy Proof-of-Concept Study.</description>
    </item>
    <item>
      <title>Mymetics Presents New Data Regarding Cold Chain Independent Virosome Based Vaccines</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-presents-new-data-regarding-cold-chain-independent-virosome-based-vaccines</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-presents-new-data-regarding-cold-chain-independent-virosome-based-vaccines</guid>
      <pubDate>Wed, 14 Nov 2018 10:42:23 GMT</pubDate>
      <description>Mymetics Presents New Data Regarding Cold Chain Independent Virosome Based Vaccines.</description>
    </item>
    <item>
      <title>Mymetics presents new data regarding cold chain independent virosome based vaccines</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-presents-new-data-regarding-cold-chain-independent-virosome-based-vaccines-1</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-presents-new-data-regarding-cold-chain-independent-virosome-based-vaccines-1</guid>
      <pubDate>Wed, 14 Nov 2018 09:31:53 GMT</pubDate>
      <description>Mymetics presents new data regarding cold chain independent virosome based vaccines.</description>
    </item>
    <item>
      <title>New Mymetics data to be presented by LMIV at American Society of Tropical Medicine and Hygiene</title>
      <link>https://6ix.com/company/mymetics-corp/news/new-mymetics-data-to-be-presented-by-lmiv-at-american-society-of-tropical-medicine-and-hygiene</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/new-mymetics-data-to-be-presented-by-lmiv-at-american-society-of-tropical-medicine-and-hygiene</guid>
      <pubDate>Tue, 30 Oct 2018 07:42:42 GMT</pubDate>
      <description>New Mymetics data to be presented by LMIV at American Society of Tropical Medicine and Hygiene.</description>
    </item>
    <item>
      <title>Mymetics Starts Research Collaboration Project in Cancer Immunotherapy with eTheRNA</title>
      <link>https://6ix.com/company/mymetics-corp/news/mymetics-starts-research-collaboration-project-in-cancer-immunotherapy-with-etherna</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/mymetics-starts-research-collaboration-project-in-cancer-immunotherapy-with-etherna</guid>
      <pubDate>Tue, 16 Oct 2018 06:00:55 GMT</pubDate>
      <description>Mymetics Starts Research Collaboration Project in Cancer Immunotherapy with eTheRNA.</description>
    </item>
    <item>
      <title>New Mymetics Data Regarding Cold Chain Independent Virosome Based Vaccines to be Presented at AAPS in Washington, D.C.</title>
      <link>https://6ix.com/company/mymetics-corp/news/new-mymetics-data-regarding-cold-chain-independent-virosome-based-vaccines-to-be-presented-at-aaps-in-washington-dc</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/new-mymetics-data-regarding-cold-chain-independent-virosome-based-vaccines-to-be-presented-at-aaps-in-washington-dc</guid>
      <pubDate>Thu, 11 Oct 2018 13:37:39 GMT</pubDate>
      <description>New Mymetics Data Regarding Cold Chain Independent Virosome Based Vaccines to be Presented at AAPS in Washington, D.C..</description>
    </item>
    <item>
      <title>New Mymetics data regarding cold chain independent virosome based vaccines to be presented at AAPS in Washington, D.C.</title>
      <link>https://6ix.com/company/mymetics-corp/news/new-mymetics-data-regarding-cold-chain-independent-virosome-based-vaccines-to-be-presented-at-aaps-in-washington-dc-1</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/new-mymetics-data-regarding-cold-chain-independent-virosome-based-vaccines-to-be-presented-at-aaps-in-washington-dc-1</guid>
      <pubDate>Thu, 11 Oct 2018 12:00:00 GMT</pubDate>
      <description>New Mymetics data regarding cold chain independent virosome based vaccines to be presented at AAPS in Washington, D.C..</description>
    </item>
    <item>
      <title>DGAP-News: Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy</title>
      <link>https://6ix.com/company/mymetics-corp/news/dgap-news-anergis-and-mymetics-start-research-collaboration-project-on-the-use-of-virosomes-for-ultra-fast-allergy-immunotherapy</link>
      <guid isPermaLink="true">https://6ix.com/company/mymetics-corp/news/dgap-news-anergis-and-mymetics-start-research-collaboration-project-on-the-use-of-virosomes-for-ultra-fast-allergy-immunotherapy</guid>
      <pubDate>Mon, 23 Apr 2018 06:04:47 GMT</pubDate>
      <description>DGAP-News: Anergis and Mymetics Start Research Collaboration Project on the use of Virosomes for Ultra-Fast Allergy Immunotherapy.</description>
    </item>
  </channel>
</rss>